InsiderPulseNo transactions found.
No financial data available for MDGL.
Company may not file with SEC or CIK is unresolved.
Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline
3 Biotech Stocks to Watch for Respectable Growth Beyond AI
Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for
Madrigal (MDGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Madrigal Pharmaceuticals: Boom Or Bust In MASH? Regretfully, I'm Bearish
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Most shorted large cap stocks as of mid-April
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
Is Madrigal Pharmaceuticals (MDGL) Still Attractively Priced After Its 20% Monthly Surge?
Trump imposes tariffs on drugmakers who haven't signed MFN deals
Tango Therapeutics is the best performing healthcare stock in March